Early accumulation of interferon-γ in grafts tolerized by donor-specific blood transfusion: Friend or enemy?

Transplantation

Volumn 78, Issue 12, 2004, Pages 1747-1755

  Kitade, Hiroaki ^a   Kawai, Masaru ^a   Koshiba, Takaaki ^a   Giulietti, Annapaula ^a   Overbergh, Lut ^a   Rutgeerts, Omer ^a   Valckx, Dirk ^a   Waer, Mark ^a   Mathieu, Chantal ^a   Pirenne, Jacques ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

DSBT; IFN ; Tolerance

Indexed keywords

GAMMA INTERFERON;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; BLOOD TRANSFUSION; CELL MATURATION; CONTROLLED STUDY; GRAFT SURVIVAL; HEART GRAFT; IMMUNOLOGICAL TOLERANCE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPLEEN CELL; THYMECTOMY;

ADOPTIVE TRANSFER; ANIMALS; BLOOD TRANSFUSION; CELL TRANSPLANTATION; CYTOKINES; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; INTERFERON TYPE II; LYMPH NODES; LYMPHOCYTE CULTURE TEST, MIXED; MALE; MYOCARDIUM; RATS; RATS, INBRED STRAINS; RNA, MESSENGER; SPLEEN; THYMECTOMY; TIME FACTORS; TISSUE DONORS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION TOLERANCE; UP-REGULATION;

EID: 19944365883     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000147788.23922.5B     Document Type: Article

References (47)

1. Takatsuki M, Uemoto S, Inomata Y, et al. Weaning of immunosuppression in living donor liver transplant recipients. Transplantation 2001; 72: 449.
2. Starzl TE, Demetris AJ, Murase N, et al. The lost chord: microchimerism and allograft survival. Immunol Today 1996; 17: 577.
3. Mazariegos GV, Reyes J, Marino IR, et al. Weaning of immunosuppression in liver transplant recipients. Transplantation 1997; 63: 243.
4. Johnson CP, Munda R, Alexander JW, et al. The effect of donor-specific transfusions on rat heart allograft survival. Transplantation 1984; 38: 575.
5. Brennan DC, Mohanakumar T, Flye MW. Donor-specific transfusion and donor bone marrow infusion in renal transplantation tolerance: a review of efficacy and mechanisms. Am J Kidney Dis 1995; 26: 701.
6. Keown PA, Descamps B. Improved renal allograft survival after blood transfusion: a nonspecific, erythrocyte-mediated immunoregulatory process. Lancet 1979; 1: 20.
7. Singal DP, Joseph S. Role of blood transfusions on the induction of antibodies against recognition sites of T lymphocytes in renal transplant patients. Hum Immunol 1982; 4: 93.
8. Smith MD, Hardy G, William ID, et al. Suppressor cell numbers and activity in non-transfused renal dialysis patients. Clin Nephrol 1983; 20: 130.
9. Koshiba T, Ji P, Tanaka K, et al. Tolerance induction with FTY720 and donor-specific blood transfusion: discrepancy between heart transplantation and intestinal transplantation. Transplant Proc 2000; 32: 1255.
10. Koshiba T, Giulietti A, Van Damme B, et al. Paradoxical early upregulation of intragraft Th1 cytokines is associated with graft acceptance following donor-specific blood transfusion. Transpl Int 2003; 16: 179.
11. Rokahr KL, Sharland AF, Sun J, et al. Paradoxical early immune activation during acceptance of liver allografts compared with rejection of skin grafts in a rat model of transplantation. Immunology 1998; 95: 257.
12. Bishop GA, McCaughan GW. Immune activation is required for the induction of liver allograft tolerance: implications for immunosuppressive therapy. Liver Transpl 2001; 7: 161.
13. Yan Y, Shastry S, Richards C, et al. Posttransplant administration of donor leukocytes induces long-term acceptance of kidney or liver transplants by an activation-associated immune mechanism. J Immunol 2001; 166: 5258.
14. Koshiba T, Kitade H, Van Damme B, et al. Regulatory cell-mediated tolerance does not protect against chronic rejection. Transplantation 2003; 76: 588.
15. Ono K, Lindsey ES. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 1969; 57: 225.
16. Overbergh L, Valckx D, Waer M, et al. Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR. Cytokine 1999; 11: 305.
17. Xia G, Goebels J, Rutgeerts O, et al. Transplantation tolerance and autoimmunity after xenogeneic thymus transplantation. J Immunol 2001; 166: 1843.
18. Onodera K, Hancock WW, Graser E, et al. Type 2 helper t cell-type cytokines and the development of "infectious" tolerance in rat cardiac allograft recipients. J Immunol 1997; 158: 1572.
19. Zelenika D, Adams E, Humm S, et al. Regulatory t cells overexpress a subset of Th2 gene transcripts. J Immunol 2002; 168: 1069.
20. Flye MW, Burton K, Mohanakumar T, et al. Donor-specific transfusions have long-term beneficial effects for human renal allografts. Transplantation 1995; 60: 1395.
21. Bushell A, Karim M, Kingsley CI, et al. Pretransplant blood transfusion without additional immunotherapy generates CD25+CD4+ regulatory T cells: a potential explanation for the blood-transfusion effect. Transplantation 2003; 76: 449.
22. D'Elios MM, Josien R, Manghetti M, et al. Predominant Th1 cell infiltration in acute rejection episodes of human kidney grafts. Kidney Int 1997; 51: 1876.
23. Cunningham DA, Dunn MJ, Yacoub MH, et al. Local production of cytokines in the human cardiac allograft. A sequential study. Transplantation 1994; 57: 1333.
24. Nast CC, Zuo XJ, Prehn J, et al. Gamma-interferon gene expression in human renal allograft fine-needle aspirates. Transplantation 1994; 57: 498.
25. Rosenberg AS, Finbloom DS, Maniero TG, et al. Specific prolongation of MHC class II disparate skin allografts by in vivo administration of anti-IFN-γ monoclonal antibody. J Immunol 1990; 144: 4648.
26. Josien R, Cuturi MC, Douillard P, et al. Recombinant IFN-γ abrogates allograft tolerance induced by donor-specific blood transfusion by restoring alloantibody production. Eur J Immunol 1999; 29: 317.
27. Bishop GA, Wang C, Sharland AF, et al. Spontaneous acceptance of liver transplants in rodents: evidence that liver leucocytes induce recipient T-cell death by neglect. Immunol Cell Biol 2002; 80: 93.
28. Lenardo MJ. Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. Nature 1991; 353: 858.
29. Dalton DK, Haynes L, Chu CQ, et al. Interferon gamma eliminates responding CD4 T cells during mycobacterial infection by inducing apoptosis of activated CD4 T cells. J Exp Med 2000; 192: 117.
30. Kishimoto K, Sandner S, Imitola J, et al. Th1 cytokines, programmed cell death, and alloreactive T cell clone size in transplant tolerance. J Clin Invest 2002; 109: 1471.
31. Zand MS, Li Y, Hancock W, et al. Interleukin-2 and interferon-gamma double knockout mice reject heterotopic cardiac allografts. Transplantation 2000; 70: 1378.
32. Konieczny BT, Dai Z, Elwood ET, et al. IFN-γ is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways. J Immunol 1998; 160: 2059.
33. Halloran PF, Miller LW, Urmson J, et al. IFN-γ alters the pathology of graft rejection: protection from early necrosis. J Immunol 2001; 166: 7072.
34. Dalton DK, Pitts-Meek S, Keshav S, et al. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 1993; 259: 1739.
35. Fairchild RL. The YIN AND YANG of IFN-γ in ALLOGRAFT rejection. Am J Transplant 2003; 3: 913.
36. Mele TS, Kneteman NM, Zhu LF, et al. IFN-γ is an Absolute Requirement for Spontaneous Acceptance of Liver Allografts. Am J Transplant 2003; 3: 942.
37. Sawitzki BS, Kingsley C, Karim M, et al. Interferon gamma is rapidly upregulated in CD4+ CD25+ regulatory T cells after in vivo antigen stimulation. Transplantation 2002; 74: 318.
38. Kawai M, Kitade H, Mathieu C, et al. Rapid presence of CD4+/CD45RC-regulatory cells in tolerated grafts: evidence for a protective role in the tolerated tissues. Am J Transplant 2004; 4(S8): 421.
39. Jaques BC, Ahmiedat H, Alastair GJ, et al. Thymus-dependent, anti-CD4-induced tolerance to rat cardiac allografts. Transplantation 1998; 66: 1291.
40. Chiffoleau E, Beriou G, Dutartre P, et al. Role for thymic and splenic regulatory CD4+ T cells induced by donor dendritic cells in allograft tolerance by LF15-0195 treatment. J Immunol 2002; 168: 5058.
41. Onodera K, Volk HD, Ritter T, et al. Thymus requirement and antigen dependency in the "infectious" tolerance pathway in transplant recipients. J Immunol 1998; 160: 5765.
42. Carlquist JF, Edelman LS, White W, et al. Cytokines and rejection of mouse cardiac allografts. Transplantation 1996; 62(8): 1160.
43. Wu CY, Kirman JR, Rotte MJ, et al. Distinct lineages of T(h)1 cells have differential capacities for memory cell generation in vivo. Nat Immunol 2002; 3: 852.
44. van Twuyver E, Mooijaart RJ, ten Berge IJ, et al. High-affinity cytotoxic T lymphocytes after non-HLA-sharing blood transfusion-the other side of the coin. Transplantation 1994; 57: 1246.
45. Dallman MJ, Wood KJ, Morris PJ. Specific cytotoxic T cells are found in the nonrejected kidneys of blood transfused rats. J Exp Med 1987; 165: 566.
46. Armstrong HE, Bolton EM, McMillan I, et al. Prolonged survival of actively enhanced rat renal allografts despite accelerated cellular infiltration and rapid induction of both class I and class II MHC antigens. J Exp Med 1987; 164: 891.
47. Koshiba T, Van Damme B, Ji P, et al. Addition of steroids blocks the tolerogenic potential of donor-specific blood transfusion. Transplant Proc 2001; 33: 375.